Leadership
The COPDforum leadership is comprised of renowned researchers/clinicians in COPD, who have contributed significantly
to the developments in this field. This global group represents some of the world's thought leaders in this area,
who are prominent in respiratory publications, international and local societies and research initiatives. Click on the
links below to learn more about the COPDforum leadership.
Leadership
Marc L. A. Decramer
MD, PhD, Professor of Medicine
Belgium
Place of work
Catholic University of Leuven.
Experience
Marc Decramer is Professor and Vice-Dean in the Faculty of Medicine, Chief of the Respiratory Division and Chief of the Pneumonology Laboratory, and Director of the Respiratory Rehabilitation Division at the University Hospitals at the Catholic University of Leuven. He qualified at the Catholic University of Leuven and did his postgraduate training in Leuven and Montréal, Canada.
Professor Decramer served on many national and international committees, and is a former President of the Belgian Pneumology Association. He was also the Editor of the European Respiratory Journal from 1999 to 2002. He currently serves on the Program Committee of the American Thoracic Society (ATS) Respiratory Structure and Function Assembly and is a member of the Editorial Board of the American Journal of Respiratory and Critical Medicine.
Professor Decramer has authored over 200 academic papers of which a selection of the most recent are listed below.
Recent publications
Troosters T, Langer D, Vrijsen B, Segers J, Wouters K, Janssens W, Gosselink R, Decramer M, Dupont L. Skeletal muscle weakness, exercise tolerance and Physical activity in adults with Cystic Fibrosis. Eur Respir J 2008 Aug 20. [Epub ahead of print]
Decramer M, Nici L, Nardini S, Reardon J, Rochester CL, Sanguinetti CM, Troosters T. Targeting the COPD exacerbation. Respir Med 2008;102 Suppl 1:S3–15.
Decramer M, Rennard S, Troosters T, Mapel DW, Giardino N, Mannino D, Wouters E, Sethi S, Cooper CB. COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention. COPD 2008;5(4):235–56.
Cooper CB, Decramer M. Inhaled steroids and COPD. Eur Respir J 2008;32(2):523–4.
Simoens S, Decramer M. A pharmacoeconomic review of the management of respiratory tract infections with moxifloxacin. Expert Opin Pharmacother 2008;9(10):1735–44.
Pitta F, Troosters T, Probst VS, Langer D, Decramer M, Gosselink R. Are patients with COPD more active after pulmonary rehabilitation? Chest 2008;134(2):273–80.
Langer D, Troosters T, Decramer M, Gosselink R. Grading recommendations: a matter of interpretation. Chest 2008;133(3):830.
Spruit MA, Troosters T, Gosselink R, Kasran A, Decramer M. Acute inflammatory and anabolic systemic responses to peak and constant-work-rate exercise bout in hospitalized patients with COPD. Int J Chron Obstruct Pulmon Dis 2007;2(4):575–83.
Tashkin DP, Celli B, Decramer M, Liu D, Burkhart D, Cassino C, Kesten S. Bronchodilator responsiveness in patients with COPD. Eur Respir J 2008;31(4):742–50.
Martin M, Moore L, Quilici S, Decramer M, Simoens S. A cost-effectiveness analysis of antimicrobial treatment of community-acquired pneumonia taking into account resistance in Belgium. Curr Med Res Opin 2008;24(3):737–51.
Hens G, Vanaudenaerde BM, Bullens DM, Piessens M, Decramer M, Dupont LJ, Ceuppens JL, Hellings PW. Sinonasal pathology in nonallergic asthma and COPD: 'united airway disease' beyond the scope of allergy. Allergy 2008;63(3):261–7.
Janssens W, VandenBrande P, Hardeman E, De Langhe E, Philps T, Troosters T, Decramer M. Inspiratory flow rates at different levels of resistance in elderly COPD patients. Eur Respir J 2008;31(1):78–83.
Crul T, Spruit MA, Gayan-Ramirez G, Quarck R, Gosselink R, Troosters T, Pitta F, Decramer M. Markers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patients. Eur J Clin Invest 2007;37(11):897–904.